GPT and cancer: Moreover, the absence of ATRX/DAXX triggers recombination-based repair at telomeres, thereby contributing to therapeutic resistance in ALT-positive cancers-particularly noted in gliomas and sarcomas’ therapy where conventional methods are ineffective [37,38,39].